Tell us about your search experience on the TGA website - complete our short survey
Notice for riltozinameran (Pfizer Australia Pty Ltd)
Active ingredients
riltozinameran
Sponsor
Date of review outcome
Lapse date
Type
Provisional determination
Indication
Active immunisation to prevent coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2